獲納入富時全球股票指數系列,開拓藥業-B漲超6%、海普瑞漲超3%
uSMART盈立智投11月23日消息,週一港股早盤,"富時全球股票指數新貴們"普漲,截至10:12分,開拓藥業-B漲6.87%、康方生物-B漲3.67%、海普瑞漲3.57%、祖龍娛樂漲2.86%、移卡漲1.07%、思摩爾國際0.72%。
11月21日,國際指數編制公司富時羅素公佈了旗艦指數2020年11月的季度審議結果。公告顯示,其旗艦指數富時全球股票指數系列(下稱“富時GEIS”)本次調整不大,A股方面僅新納入國聯證券一隻個股,此次調整將於12月18日收盤後正式生效。
名單顯示,大盤股新納入思摩爾國際(港股)、泰格醫藥(港股)、理想汽車(美股)、金山雲(美股)、達達集團(美股)等5家中國公司;
中盤股中新增海普瑞(港股)、國聯證券(A股)等2家中國公司;
小盤股中新增康方生物-B(港股)移卡(港股)、祖龍娛樂(港股)等3家中國公司;
微盤股新增滿貫集團、虎視傳媒、永泰生物、鳳祥股份、金融界物業、開拓藥業-B、趣活、弘陽服務、藍城兄弟、嘉興燃氣、宏力醫療管理、新娛科控股、力天影業等13家港股公司。剔除個股方面,不涉及中國公司。
需要注意的是,此次公佈的只是初步名單,富時羅素還將根據市場情況對上述名單進行小幅調整,最終納入名單將在指數生效日前確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.